Halluzinogene, Amphetamine und Entactogene
Franz X. Vollenweider, M. F. I. Vollenweider-Scherpenhuyzen
Therapeutische Umschau June 1, 2003 DOI: 10.1024/0040-5930.60.6.323 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Amphetamine |
| Citations | 3 |
| Key findings | A recent survey suggests a revival of classic amphetamine and hallucinogen abuse, possibly due to concerns about ecstasy's neurotoxicity and somatic risks. |
Abstract
MDMA ("Ecstasy") and its analogues such as MDE and MDA are amphetamine derivatives reported to produce an altered state with emotional overtones. Since more than ten years, ecstasy is after cannabis the most frequently used recreational drug by young adults, particularly in the so-called techno-scene. However, according to a recent survey there is an increasing trend for a revival of classic amphetamine and hallucinogen abuse, possibly due to the concern about the potential neurotoxicity and somatic risks associated with ecstasy use. Of the hallucinogens consumed, psilocybin containing mushroom ("magic mushrooms"), but also LSD are at the forefront. The present contribution summarizes the psychological and somatic effects of hallucinogens, amphetamines, and entactogens.
Citations in the library
Cited by 2
Cites 5
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- Gender differences in the subjective effects of MDMA Psychopharmacology March 5, 2001
- Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies Human Psychopharmacology: Clinical and Experimental December 1, 2001
- The Background and Chemistry of MDMA Journal of Psychoactive Drugs October 1, 1986
- MDMA("Ecstasy")-Konsum - ein Überblick zu psychiatrischen und medizinischen Folgen Fortschritte der Neurologie · Psychiatrie February 1, 1997